Hyperfine, Inc. (HYPR) stock
HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 9/3021% below fair value
$0.61−0.02 (-3.05%)
Close on Nov 16, 2026Market cap $64.70MP/E –Yield –
Hyperfine cash
Cash and short-term investments held at the end of each period.
Hyperfine's cash was $43.46M at Jun 30, 2026. For fiscal 2025 it was $35.09M, down 6.9% from the year before. The highest annual figure on record is $191.16M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $35.09M | -6.9% |
| FY2024 | Dec 31, 2024 | $37.67M | -50.3% |
| FY2023 | Dec 31, 2023 | $75.80M | -35.9% |
| FY2022 | Dec 31, 2022 | $118.24M | -38.1% |
| FY2021 | Dec 31, 2021 | $191.16M | +197.4% |
| FY2020 | Dec 31, 2020 | $64.29M | +143.1% |
| FY2019 | Dec 31, 2019 | $26.44M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $43.46M | +71.0% |
| Q1 FY2026 | Mar 31, 2026 | $40.78M | +23.2% |
| Q4 FY2025 | Dec 31, 2025 | $35.09M | -6.9% |
| Q3 FY2025 | Sep 30, 2025 | $21.56M | -52.9% |
| Q2 FY2025 | Jun 30, 2025 | $25.42M | -52.8% |
| Q1 FY2025 | Mar 31, 2025 | $33.09M | -47.6% |
| Q4 FY2024 | Dec 31, 2024 | $37.67M | -50.3% |
| Q3 FY2024 | Sep 30, 2024 | $45.77M | -46.4% |
| Q2 FY2024 | Jun 30, 2024 | $53.81M | -42.7% |
| Q1 FY2024 | Mar 31, 2024 | $63.20M | -39.2% |
| Q4 FY2023 | Dec 31, 2023 | $75.80M | -35.9% |
| Q3 FY2023 | Sep 30, 2023 | $85.42M | -35.5% |
| Q2 FY2023 | Jun 30, 2023 | $93.95M | -35.3% |
| Q1 FY2023 | Mar 31, 2023 | $104.03M | -35.6% |
| Q4 FY2022 | Dec 31, 2022 | $118.24M | -38.1% |
| Q3 FY2022 | Sep 30, 2022 | $132.48M | +102.3% |
| Q2 FY2022 | Jun 30, 2022 | $145.10M | +87.5% |
| Q1 FY2022 | Mar 31, 2022 | $161.58M | +87.4% |
| Q4 FY2021 | Dec 31, 2021 | $191.16M | +197.4% |
| Q3 FY2021 | Sep 30, 2021 | $65.48M | +147.6% |
| Q2 FY2021 | Jun 30, 2021 | $77.39M | – |
| Q1 FY2021 | Mar 31, 2021 | $86.23M | – |
| Q4 FY2020 | Dec 31, 2020 | $64.29M | – |
| Q4 FY2019 | Dec 31, 2019 | $26.44M | – |
See a number that looks wrong?